Evidence map›Paper›PMID 41586517›Full record

ArticlemBio2026

The adenovirus oncoprotein E1B-55K reshapes epigenetic histone modifications in primary human cells.

Konstantin von Stromberg, Laura Seddar, Britta Gornott, Thomas Dobner, Luca D Bertzbach, Wing-Hang Ip

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Konstantin von StrombergLeibniz Institute of Virology (LIV), Hamburg, Germany.ORCID 0009-0003-7385-7953
Laura SeddarLeibniz Institute of Virology (LIV), Hamburg, Germany.
Britta GornottLeibniz Institute of Virology (LIV), Hamburg, Germany.
Thomas DobnerLeibniz Institute of Virology (LIV), Hamburg, Germany.ORCID 0000-0001-7392-8588
Luca D BertzbachLeibniz Institute of Virology (LIV), Hamburg, Germany.ORCID 0000-0002-0698-5395
Wing-Hang IpLeibniz Institute of Virology (LIV), Hamburg, Germany.ORCID 0000-0002-5367-1401

Funding

Wilhelm Sander-Stiftung R2024.123.1
6 · The paper itself

Abstract

Oncogenic viruses can induce epigenetic changes in host cells, which may contribute to cell transformation and tumorigenesis by altering gene expression patterns. Human adenoviruses, while primarily known for their lytic infections, have also been implicated in oncogenic transformation in experimental settings, but the mechanisms underlying adenovirus oncoprotein-induced epigenetic dysregulation remain poorly defined. Building on our recent findings that the adenoviral oncoprotein E1B-55K coordinates cellular transformation through interactions with DNA-bound host transcription factors, we next sought to determine whether these interactions also influence the chromatin landscape. For this purpose, we investigated the epigenetic consequences of E1B-55K expression in primary human mesenchymal stromal cells using histone-targeting MNase chromatin immunoprecipitation-seq, complemented by RNA-seq analysis. We demonstrate that stable expression of HAdV-C5 E1B-55K leads to widespread changes in histone post-translational modifications across the genome. Most notably, E1B-55K expression results in a marked loss of the activating histone marks H3K4me3 and H3K27ac at specific promoters and enhancers. These epigenetic alterations correspond with significant changes in gene expression, suggesting that E1B-55K interferes with normal transcriptional programming by altering the establishment of key histone modifications. Our findings help explain how E1B-55K drives viral transformation by changing epigenetic patterns and improving our understanding of virus-host interactions at the chromatin level. By describing how human adenoviruses disrupt epigenetic homeostasis, we provide insights into the mechanisms by which oncogenic viruses promote early events in cellular transformation.IMPORTANCEOncogenic viruses can reshape host cell epigenomes to promote transformation, yet the mechanisms by which adenoviral oncogenes exert such control remain poorly understood. Here, we reveal that the human adenovirus E1B-55K oncoprotein induces widespread loss of activating histone modifications, leading to transcriptional silencing of key cellular genes in primary human cells. Building on our previous demonstration of efficient adenoviral transformation of primary human mesenchymal stromal cells, this study provides the first comprehensive view of E1B-55K-mediated epigenetic reprogramming. Our findings uncover a link between E1B-55K-host transcription factor interactions and chromatin remodeling, offering new insight into how adenoviruses disrupt epigenetic homeostasis to initiate early events in oncogenic transformation. These results provide direct evidence for the transcriptional repression function long postulated for E1B-55K and advance understanding of virus-host interplay at the chromatin level.

Indexed as

Adenovirus E1B ProteinsAdenoviruses, HumanEpigenesis, GeneticHistone CodeHistonesCells, CulturedCell Transformation, ViralChromatinHost-Pathogen InteractionsHumansMesenchymal Stem CellsProtein Processing, Post-TranslationalViral ProteinsAdenovirus E1B ProteinsChromatinE1B55K protein, adenovirusHistonesViral ProteinsadenoviruschromatinepigeneticsH3K27acH3K4me3histone modificationsoncogenetransduction

Identifiers

PMID41586517
PMCPMC12977564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.